scholarly journals Sexually transmitted infection with an immune-escape mutant hepatitis B virus (HBV) in an HBV-vaccinated individual with acute HIV-HCV infection

2012 ◽  
Vol 15 (6(Suppl 4)) ◽  
Author(s):  
P Ingiliz ◽  
I Krznaric ◽  
D Behrendt ◽  
A Baumgarten ◽  
T Berg ◽  
...  
2009 ◽  
Vol 83 (19) ◽  
pp. 9983-9992 ◽  
Author(s):  
Sibnarayan Datta ◽  
Rajesh Panigrahi ◽  
Avik Biswas ◽  
Partha K. Chandra ◽  
Arup Banerjee ◽  
...  

ABSTRACT The compartmentalization of viral variants in distinct host tissues is a frequent event in many viral infections. Although hepatitis B virus (HBV) classically is considered hepatotropic, it has strong lymphotropic properties as well. However, unlike other viruses, molecular evolutionary studies to characterize HBV variants in compartments other than hepatocytes or sera have not been performed. The present work attempted to characterize HBV sequences from the peripheral blood leukocytes (PBL) of a large set of subjects, using advanced molecular biology and computational methods. The results of this study revealed the exclusive compartmentalization of HBV subgenotype Ae/A2-specific sequences with a potent immune escape G145R mutation in the PBL of the majority of the subjects. Interestingly, entirely different HBV genotypes/subgenotypes (C, D, or Aa/A1) were found to predominate in the sera of the same study populations. These results suggest that subgenotype Ae/A2 is selectively archived in the PBL, and the high prevalence of G145R indicates high immune pressure and high evolutionary rates of HBV DNA in the PBL. The results are analogous to available literature on the compartmentalization of other viruses. The present work thus provides evidence in favor of the compartment-specific abundance, evolution, and emergence of the potent immune escape mutant. These findings have important implications in the field of HBV molecular epidemiology, transmission, transfusion medicine, organ transplantation, and vaccination strategies.


1995 ◽  
Vol 146 (6) ◽  
pp. 397-407 ◽  
Author(s):  
F. Ni ◽  
D. Fang ◽  
R. Gan ◽  
Z. Li ◽  
S. Duan ◽  
...  

2005 ◽  
Vol 86 (6) ◽  
pp. 1687-1693 ◽  
Author(s):  
Séverine Margeridon ◽  
Alain Lachaux ◽  
Christian Trepo ◽  
Fabien Zoulim ◽  
Alan Kay

Hepatitis B virus (HBV) infections can be prevented or controlled by the host humoral immune response (anti-HBs) directed against the major surface antigen (HBsAg), elicited either naturally or by vaccination. A chronic HBV carrier was found to have high levels of both virus and anti-HBs. Full-length HBV genomes were amplified from the patient's serum, sequenced and cloned. The genome was ‘wild-type’ HBV of genotype C and serotype adr. The sequence has remained stable, with no signs of emergence of an immune-escape mutant population. To study what was recognized by the patient's serum, viral particles were 35S-labelled and then immunoprecipitated by using the patient's serum or control sera. The patient's serum immunoprecipitated the adr HBsAg encoded by his HBV genome poorly, but efficiently recognized HBsAg of serotype ayw. When his HBV genome was modified by a point mutation to express HBsAg of serotype ayr, the patient's serum could recognize the antigen, as well as the control anti-HBs-positive serum. The patient appeared to have made a quasi-monoclonal humoral response to the y epitope. By switching to the d epitope, which requires only a point mutation, the virus could replicate, despite the high levels of anti-HBs. This study underlines the subtleties of virus–host interactions. Implications for HBV vaccination are discussed.


Sign in / Sign up

Export Citation Format

Share Document